Table 1.
Groups |
Serum iron
( μ mol/L) |
TIBC
( μ mol/L) |
TS% |
HEPC (ng/ml) |
Ferritin (ng/ml) |
NTBI (μmol/L) |
---|---|---|---|---|---|---|
Control | 18.50±0.640 | 38.52±0.168 | 48.02±1.474 | 4.97±0.07 | 24.87±0.52 | 1.83±0.140 |
DFO | 18.40±0.590 | 38.83±0.293 | 47.82±1.259 | 4.71±0.08 | 23.61±0.54 | 1.51 ±0.257 |
Quercetin | 18.25±0.602 | 38.17±0.333 | 47.42±1.265 | 4.99±0.08 | 23.61±0.55 | 1.54±0.076 |
Iron | 69.17±3.16 a | 73.43±2.68a | 92.48±2.091 a | 26.41±0.24a | 61.83±1.45a | 20.67±1.78a |
Iron + DFO | 21.53±1.25b | 40.00±0.516b | 53.89±2.335 b | 10.59±0.38b | 30.24±0.51b | 2.05±0.292b |
Iron+Quercetin | 20.80± 0.957b,c | 39.51±0.541b,d | 52.64±2.321b,d | 10.49±0.25b,c | 32.31±1.37b,c | 2.06±0.856b,c |
| ||||||
P-Value | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
| ||||||
LSD 0.05 | 3.5301 | 3.120 | 4.9601 | 0.624 | 2.651 | 1.7504 |
Values are expressed as means ±standard error (n=6), LSD: least significance difference DFO: Deferoxamine, TIBC: total iron binding capacity, HEPC: hepcidin, and NTBI: nontransferrin bound iron.
a: highly significant difference as compared to control group (P< 0.001).
b: highly significant difference as compared to iron overload group (P< 0.001).
c: non-significant difference as compared to iron + DFO group (P > 0.05).
d: significant difference as compared to iron + DFO group (P < 0.05).